Free tool
Dividend paying stocks
We cover 130 companies that currently pay a dividend. The median market value in the group is $42.09B. Across the group, the median move over the past trading day is 0.00%. 61% of the 127 with a 200-day average trade above it. Price change over the past year runs from −36.1% to +41.0% across the middle 80 percent of the group, with a median of +5.2%.
Other lists in this group
Table
130 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| ABTT34.SA | Abbott Laboratories | 49.40 BRL | +7.95% | −11.54% | −16.35% |
| ABT | Abbott Laboratories | $114.10 | +6.37% | −7.08% | −11.83% |
| GILD | Gilead Sciences, Inc. | $148.09 | +10.25% | +22.48% | +32.51% |
| GIS.DE | Gilead Sciences, Inc. | 126.78 EUR | +7.51% | +23.41% | +33.64% |
| GILD34.SA | Gilead Sciences, Inc. | 63.72 BRL | −81.50% | −81.40% | −79.11% |
| PFIZ34.SA | Pfizer Inc. | 36.48 BRL | +12.73% | +10.34% | +11.58% |
| PFE | Pfizer Inc. | $28.30 | +12.08% | +16.16% | +18.72% |
| PFE.DE | Pfizer Inc. | 24.44 EUR | +10.09% | +18.44% | +22.96% |
| DHER34.SA | Danaher Corporation | 39.85 BRL | +9.12% | −10.44% | +0.89% |
| DAP.DE | Danaher Corporation | 184.45 EUR | +4.06% | −5.68% | +6.90% |
| DHR | Danaher Corporation | $215.36 | +8.19% | −6.33% | +5.61% |
| BMYB34.SA | Bristol-Myers Squibb Company | 349.41 BRL | +12.49% | +17.24% | +40.74% |
| BMY | Bristol-Myers Squibb Company | $67.57 | +6.24% | +27.70% | +47.01% |
| BRM.DE | Bristol-Myers Squibb Company | 58.02 EUR | +3.74% | +28.56% | +50.84% |
| SYK.DE | Stryker Corporation | 282.40 EUR | −8.40% | −4.46% | +34.90% |
| S1YK34.SA | Stryker Corporation | 84.97 BRL | −3.57% | −13.76% | −19.51% |
| SYK | Stryker Corporation | $329.67 | −4.88% | −5.06% | −15.52% |
| MDTC34.SA | Medtronic plc | 59.52 BRL | +13.44% | −77.24% | −75.74% |
| MDT | Medtronic plc | $92.02 | +5.92% | −3.41% | +2.29% |
| 2M6.DE | Medtronic plc | 78.54 EUR | +1.19% | −2.78% | +2.65% |
| SNW.DE | Sanofi | 78.75 EUR | −1.46% | +0.80% | −2.82% |
| SAN.PA | Sanofi | 78.74 EUR | −1.48% | +1.00% | −2.60% |
| SNY | Sanofi | $45.42 | −0.26% | −0.60% | −4.33% |
| G1SK34.SA | GSK plc | 53.80 BRL | +4.47% | +1.87% | +27.31% |
| M1CK34.SA | McKesson Corporation | 72.17 BRL | +2.08% | −93.69% | −92.49% |
| MCK | McKesson Corporation | $896.65 | +0.80% | +8.98% | +31.57% |
| GSK | GSK plc | $51.43 | −4.25% | +5.41% | +32.23% |
| GSK.L | GSK plc | 1,905.50 GBP | −5.06% | +4.06% | +30.59% |
| GS71.DE | GSK plc | 22.35 EUR | −4.49% | +7.86% | +34.79% |
| HCA | HCA Healthcare, Inc. | $427.16 | +2.14% | −9.06% | +5.96% |
| H1CA34.SA | HCA Healthcare, Inc. | 112.22 BRL | +4.87% | −11.77% | +2.99% |
| A58.DE | Elevance Health, Inc. | 342.50 EUR | +2.03% | +13.81% | −19.30% |
| ELV | Elevance Health, Inc. | $402.54 | +4.36% | +14.33% | +32.12% |
| E1LV34.SA | Elevance Health, Inc. | 410.80 BRL | +3.62% | +6.85% | +21.66% |
| ESL.DE | EssilorLuxottica Société anonyme | 160.00 EUR | −2.85% | −38.15% | −39.11% |
| EL.PA | EssilorLuxottica Société anonyme | 159.15 EUR | −3.60% | −38.64% | −38.15% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | 70.98 BRL | +20.22% | +2.34% | +33.80% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | 717.90 EUR | +25.00% | +8.96% | −5.91% |
| REGN | Regeneron Pharmaceuticals, Inc. | $814.79 | +17.21% | +5.24% | +39.36% |
| CGN.DE | The Cigna Group | 237.40 EUR | −9.42% | +0.45% | −8.78% |
| CI | The Cigna Group | $280.87 | −6.71% | +1.18% | −4.84% |
| C1IC34.SA | The Cigna Group | 59.58 BRL | −3.85% | −84.24% | −85.33% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | 6,953.00 JPY | −1.64% | −18.35% | +9.21% |
| MRK.DE | Merck KGaA | 139.35 EUR | −3.96% | +17.18% | +32.17% |
| COR | Cencora, Inc. | $327.79 | +2.57% | −2.88% | +13.45% |
| CSL.AX | CSL Limited | 173.59 AUD | +35.54% | +2.25% | −16.37% |
| TAK | Takeda Pharmaceutical Company Limited | $18.23 | +4.05% | +16.71% | +22.68% |
| 4502.T | Takeda Pharmaceutical Company Limited | 5,791.00 JPY | −0.96% | +19.85% | +36.03% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | 92.25 BRL | +2.81% | +12.61% | +18.03% |
| BAYN.DE | Bayer Aktiengesellschaft | 49.26 EUR | +3.29% | +30.00% | +76.91% |
| BAY.WA | Bayer Aktiengesellschaft | 210.50 PLN | +2.53% | +34.11% | +76.59% |
| C1AH34.SA | Cardinal Health, Inc. | 1,234.64 BRL | +2.68% | +6.79% | +52.41% |
| CAH | Cardinal Health, Inc. | $238.40 | +2.53% | +16.17% | +61.05% |
| C1CO34.SA | Cencora, Inc. | 707.04 BRL | 0.00% | −22.88% | −12.17% |
| BOX.DE | Becton, Dickinson and Company | 168.80 EUR | +23.08% | +2.38% | +1.73% |
| BDX | Becton, Dickinson and Company | $190.21 | +14.35% | +24.91% | +25.97% |
| B1DX34.SA | Becton, Dickinson and Company | 195.72 BRL | +39.80% | −113.58% | −113.87% |
| 7741.T | HOYA Corporation | 24,525.00 JPY | +3.20% | +2.32% | +28.99% |
| SHL.DE | Siemens Healthineers AG | 39.70 EUR | +5.75% | −7.90% | −14.18% |
| HUM | Humana Inc. | $391.06 | +0.60% | +48.61% | +33.14% |
| H1UM34.SA | Humana Inc. | 44.52 BRL | +0.95% | +39.09% | +24.36% |
| H6D0.DE | Haleon plc | 4.34 EUR | −3.02% | +2.63% | +5.39% |
| HLN | Haleon plc | $10.17 | −0.97% | +3.05% | +6.13% |
| HLN.L | Haleon plc | 369.60 GBP | −2.66% | −0.12% | +2.68% |
| A | Agilent Technologies, Inc. | $155.08 | +10.35% | +12.88% | +31.46% |
| 4578.T | Otsuka Holdings Co., Ltd. | 12,260.00 JPY | +6.56% | +35.48% | +57.62% |
| A1GI34.SA | Agilent Technologies, Inc. | 72.26 BRL | +7.99% | −81.18% | −77.37% |
| RPRX | Royalty Pharma plc | $61.80 | +3.05% | +60.57% | +74.00% |
| 2U3.DE | Alcon Inc. | 62.62 EUR | +2.25% | −4.76% | −7.70% |
| ALC | Alcon Inc. | $72.67 | +5.15% | −5.89% | −10.24% |
| RMD | ResMed Inc. | $235.69 | +12.79% | −3.22% | −15.77% |
| RMD.AX | ResMed Inc. | 32.47 AUD | +8.27% | −9.89% | −24.75% |
| GEHC | GE HealthCare Technologies Inc. | $73.31 | +14.35% | −11.40% | −1.15% |
| 4568.T | Daiichi Sankyo Company, Limited | 2,874.50 JPY | −0.42% | −17.47% | −17.94% |
| ZOE.DE | Zoetis Inc. | 65.74 EUR | −4.92% | −38.01% | −49.47% |
| ZTS | Zoetis Inc. | $77.52 | +0.01% | −37.91% | −49.50% |
| Z1TS34.SA | Zoetis Inc. | 24.94 BRL | +0.56% | −40.91% | −52.31% |
| 068270.KS | Celltrion, Inc. | 190,900.00 KRW | +6.06% | −5.73% | +11.19% |
| FRE.DE | Fresenius SE & Co. KGaA | 45.85 EUR | +2.98% | −1.28% | +1.64% |
| LH | Labcorp Holdings Inc. | $335.72 | +6.84% | +33.74% | +21.14% |
| R1MD34.SA | ResMed Inc. | 243.85 BRL | 0.00% | −26.80% | −38.24% |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% |
| 4503.T | Astellas Pharma Inc. | 2,392.50 JPY | +4.23% | +14.03% | +53.57% |
| PHG | Koninklijke Philips N.V. | $26.99 | +5.64% | +3.59% | +1.27% |
| PHI1.DE | Koninklijke Philips N.V. | 23.42 EUR | +2.76% | +5.23% | +3.22% |
| WST | West Pharmaceutical Services, Inc. | $349.92 | +3.90% | +26.81% | +42.61% |
| 4543.T | Terumo Corporation | 2,557.50 JPY | +7.35% | +13.84% | −2.68% |
| STE | STERIS plc | $236.77 | +2.79% | −5.07% | −4.41% |
| DIM.PA | Sartorius Stedim Biotech S.A. | 194.30 EUR | +13.49% | −6.30% | +11.64% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | 194.20 EUR | +13.30% | −7.09% | +11.32% |
| SIG.AX | Sigma Healthcare Limited | 2.59 AUD | −13.09% | −11.26% | −15.21% |
| S1TE34.SA | STERIS plc | 52.14 BRL | 0.00% | −19.10% | −18.78% |
| SRT3.DE | Sartorius Aktiengesellschaft | 246.50 EUR | +9.26% | −0.18% | +25.88% |
| VIA.DE | Viatris Inc. | 14.27 EUR | −9.28% | +38.01% | +67.32% |
| VTRS | Viatris Inc. | $16.85 | −5.66% | +37.39% | +66.19% |
| ZBH | Zimmer Biomet Holdings, Inc. | $101.38 | +5.88% | +12.93% | −4.32% |
| QS51.DE | Straumann Holding AG | 98.00 EUR | −5.77% | −3.14% | −1.10% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | 121.92 BRL | +6.75% | +6.21% | −5.04% |
| IPN.PA | Ipsen S.A. | 166.00 EUR | +1.41% | +42.98% | +40.80% |
| COLO-B.CO | Coloplast A/S | 462.50 DKK | +6.22% | −12.68% | −20.60% |
| CBHD.DE | Coloplast A/S | 61.54 EUR | +5.85% | −5.48% | +7.91% |
| SRT.DE | Sartorius Aktiengesellschaft | 195.00 EUR | +9.92% | +0.74% | +21.79% |
| 4507.T | Shionogi & Co., Ltd. | 2,892.00 JPY | −5.80% | +2.05% | +15.63% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | 36.47 AUD | +5.19% | +12.67% | +11.27% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | 35.30 BRL | +2.86% | −12.41% | +1.37% |
| ESF0.DE | Eurofins Scientific SE | 72.70 EUR | +7.58% | +17.51% | +12.65% |
| ERF.PA | Eurofins Scientific SE | 74.08 EUR | +7.93% | +20.90% | +15.60% |
| 7733.T | Olympus Corporation | 2,162.50 JPY | +16.11% | +8.42% | +27.06% |
| RVTY | Revvity, Inc. | $126.35 | +13.31% | +28.91% | +42.93% |
| BAX | Baxter International Inc. | $26.50 | +8.74% | +35.96% | +8.90% |
| PME.AX | Pro Medicus Limited | 181.86 AUD | +10.93% | −18.09% | −39.15% |
| B1AX34.SA | Baxter International Inc. | 67.70 BRL | +8.81% | +27.70% | +3.61% |
| ORNBV.HE | Orion Oyj | 80.80 EUR | −1.76% | +29.38% | +21.01% |
| ORNAV.HE | Orion Oyj | 80.50 EUR | −1.83% | +29.71% | +21.27% |
| S1NN34.SA | Smith & Nephew plc | 31.62 BRL | 0.00% | −9.99% | −20.44% |
| FME.DE | Fresenius Medical Care AG | 40.36 EUR | −7.39% | +4.49% | −2.61% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | 52.70 EUR | +2.53% | +10.68% | +1.80% |
| FMS | Fresenius Medical Care AG | $23.40 | −5.45% | +3.54% | −3.21% |
| R1VT34.SA | Revvity, Inc. | 20.60 BRL | +3.00% | +10.27% | +22.81% |
| SNN | Smith & Nephew plc | $29.30 | −10.01% | −9.54% | −19.49% |
| SN.L | Smith & Nephew plc | 1,068.00 GBP | −12.06% | −12.27% | −22.42% |
| EHC | Encompass Health Corporation | $120.78 | +4.09% | +13.77% | −1.75% |
| T1CH34.SA | Bio-Techne Corporation | 12.60 BRL | +4.13% | +17.24% | +23.42% |
| TECH | Bio-Techne Corporation | $72.38 | +0.43% | +21.73% | +29.33% |
| U1HS34.SA | Universal Health Services, Inc. | 230.44 BRL | +11.86% | −26.92% | −6.44% |
| UHS | Universal Health Services, Inc. | $178.69 | +7.50% | −18.65% | −1.76% |
| ENSG | The Ensign Group, Inc. | $180.63 | −1.37% | +3.89% | +5.01% |
| BIM.PA | bioMérieux S.A. | 75.50 EUR | +3.64% | −31.05% | −35.91% |
| RDY | Dr. Reddy's Laboratories Limited | $12.22 | +4.18% | −11.83% | −14.19% |
| RHCPA.AX | Ramsay Health Care Limited | 108.65 AUD | +0.60% | +1.45% | +1.45% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.